Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Global Cord Blood Corporation (Amendment)SC 13G/A - Global Cord Blood Corp (0001467808) (Subject)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form NT 20-F filed by Global Cord Blood CorporationNT 20-F - Global Cord Blood Corp (0001467808) (Filer)
- NEWSSmile, Please: In-N-Out Bans Employees From Wearing Masks In Texas And Four Other StatesCalifornia-based fast-food giant In-N-Out will ban employees from wearing masks in five out of its seven operational states, according to an internal memo that was leaked Friday. In-N-Out employees in California and Oregon can continue to wear masks if they would like, but employees in Arizona, Nevada, Utah, Colorado and Texas will no longer be allowed to wear masks starting Aug. 14. The policy is being implemented to help promote more effective and clear communication, according to the L.A. Times. If employees need to, they will be able to present a doctor’s note and be able to continue to wear masks. Read also: DeSantis's 'Lasting Harm' To Disney In Florida Pushes Mouse House To Boost
- SECSEC Form 25-NSE filed by Global Cord Blood Corporation25-NSE - Global Cord Blood Corp (0001467808) (Subject)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- NEWSGlobal Cord Blood Corporation Announces Failure To File Interim Financials
- PRGLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSGEORGE TOWN, Cayman Islands and HONG KONG, April 13, 2023 /PRNewswire/ -- Global Cord Blood Corporation (NYSE:CO) (the "Company"), a provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services in China, announced that it received a notice (the "Notice") on April 3, 2023 from the New York Stock Exchange ("NYSE") with respect to its failure to timely file on Form 6-K its semi-annual financials for the six-month period ended September 30, 2022 (the "Interim Financials") as required by NYSE Listing Standard 203.03. As previously announced, on September 22, 2022, the Grand Court of the Cayman Islands issued an order (the "Order") appoi
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- 13D/GSEC Form SC 13G filed by Global Cord Blood CorporationSC 13G - Global Cord Blood Corp (0001467808) (Subject)
- 13D/GSEC Form SC 13G/A filed by Global Cord Blood Corporation (Amendment)SC 13G/A - Global Cord Blood Corp (0001467808) (Subject)
- 13D/GSEC Form SC 13G filed by Global Cord Blood CorporationSC 13G - Global Cord Blood Corp (0001467808) (Subject)
- NEWS5 Value Stocks In The Healthcare SectorThe Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching: ProPhase Labs (NASDAQ:PRPH) - P/E: 5.74 Aptevo Therapeutics (NASDAQ:APVO) - P/E: 2.84 Global Cord Blood (NYSE:CO) - P/E: 5.11 Jasper Therapeutics (NASDAQ:JSPR) - P
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- SECSEC Form 6-K filed by Global Cord Blood Corporation6-K - Global Cord Blood Corp (0001467808) (Filer)
- PRGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsGlobal Cord Blood Corporation (NYSE:CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the Grand Court of the Cayman Islands ("Grand Court") on September 22, 2022 (the "Order") appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited as the Joint Provisional Liquidators of the Company (the "Joint Provisional Liquidators"). Upon the making of the Order, the powers of the directors of the Company are suspended. Blue Oce
- NEWSWhy NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From FridayGainers Golden Sun Education Group Limited (NASDAQ:GSUN) shares surged 92.1% to settle at $52.89 on Friday. Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares climbed 46.4% to close at $0.3750 on Friday. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day extension to March 13, 2023 to regain compliance. Athersys, Inc. (NASDAQ:ATHX) gained 39.3% to settle at $1.63 after the company announced it entered into amended agreements to extend the exercise period of the warrants that were issued as part of a recent registered direct offering. Snow Lake Resources Ltd. (NASDAQ:LITM) shares climbed 38.3% to settle at $3.18 following n
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Kiromic BioPharma (NASDAQ:KRBP) stock rose 71.7% to $0.44 during Friday's regular session. As of 13:30 EST, Kiromic BioPharma's stock is trading at a volume of 20.8 million, which is 3303.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.9 million. Athersys (NASDAQ:ATHX) shares increased by 53.41% to $1.79. Trading volume for Athersys's stock is 34.4 million as of 13:30 EST. This is 4708.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $547.6 million. Global Cord Blood (NYSE:CO) shares rose 33.78% to $2.97. As of 13:30 EST, this security is trading at a volum
- NEWSAnalyzing Global Cord Blood's Short InterestGlobal Cord Blood's (NYSE:CO) short percent of float has risen 5.26% since its last report. The company recently reported that it has 205 thousand shares sold short, which is 0.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.3 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short intere
CO FAQ
5 questionsWhat does Global Cord Blood Corporation do?
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to...Where does CO stock trade?
Global Cord Blood Corporation (CO) is listed on NYSE.What sector and industry is CO in?
Global Cord Blood Corporation operates in the Health Care sector, Managed Health Care industry.What companies are similar to CO?
Notable peers in the same industry include CERN (Cerner Corporation), CHNG (Change Healthcare Inc.), AGTI (Agiliti Inc.), CSLT (Castlight Health Inc.), MTBC (CareCloud Inc.). Compare CO side-by-side with any of them on Quantisnow.How can I track CO on Quantisnow?
Quantisnow aggregates Global Cord Blood Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CO to receive live email and push alerts on every new disclosure.